Alpha Teknova Inc TKNO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.11
- Day Range
- $2.00–2.16
- 52-Week Range
- $1.62–4.27
- Bid/Ask
- $2.00 / $2.10
- Market Cap
- $82.06 Mil
- Volume/Avg
- 13,356 / 10,236
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.83
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 211
- Website
- https://www.teknova.com
Comparables
Valuation
|
Metric
|
TKNO
|
TIHE
|
VCYT
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 25.08 |
Price/Book Value | — | — | 1.33 |
Price/Sales | 1.83 | — | 3.81 |
Price/Cash Flow | — | — | 28.41 |
Price/Earnings
TKNO
TIHE
VCYT
Financial Strength
|
Metric
|
TKNO
|
TIHE
|
VCYT
|
|---|---|---|---|
Quick Ratio | 3.65 | — | 4.19 |
Current Ratio | 5.14 | — | 4.66 |
Interest Coverage | −43.51 | — | −5,596.07 |
Quick Ratio
TKNO
TIHE
VCYT
Profitability
|
Metric
|
TKNO
|
TIHE
|
VCYT
|
|---|---|---|---|
Return on Assets (Normalized) | −19.81% | — | 7.85% |
Return on Equity (Normalized) | — | — | 8.41% |
Return on Invested Capital (Normalized) | −20.40% | — | 7.64% |
Return on Assets
TKNO
TIHE
VCYT
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Jbccrbshdg | Cmdfzml | $70.5 Bil | |
ZTS
| Zoetis Inc Class A | Drhzwmws | Tjbmk | $70.0 Bil | |
HLN
| Haleon PLC ADR | Hwjrwdxn | Xgy | $36.3 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Ltdjlxxlz | Txss | $14.3 Bil | |
VTRS
| Viatris Inc | Lhjxnycf | Zzmvg | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Mjykwnpd | Qxlwx | $12.0 Bil | |
CTLT
| Catalent Inc | Bhpfjsp | Fwrmnfp | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Gwngkkzc | Tlg | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Jfvldrnvl | Rzzx | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Svyrmtk | Ggxxlkr | $3.4 Bil |